Pharmalot... Pharmalittle... Good Morning

Hello, everyone, and how are you this morning? A strong sun and cool breeze are enveloping the leafy Pharmalot corporate campus, where we await the arrival of the grounds crew to tidy up. This may be a long wait, however. In the interim, yes, we are brewing a needed cup of stimulation - our flavor is the seasonal favorite, Pumpkin Spice - and we invite you to join us, as always. An extra kick at the start of the day is always welcome, yes? Now, though, the time has come to get cracking. So here are a few items of interest. Have a grand day... Glaxo Seeks To Market First Malaria Vaccine (The Guardian) The Shutdown Update On FDA Activities, Or Lack Thereof (FDA Law Blog) J&J Buys Hepatitis C Drug From GlaxoSmithKline (Investor's Business Daily) Glaxo Sales In India Hurt By Protest Over New Pricing Regime (Reuters) Biogen Says Patient Death Not Related To Tecfidera MS Drug (Wall Street Journal) Bayer To Bring Five Drugs To Late-Stage Trials By 2015 (RTT News) Pfizer R&D Chief Tries Fine-Tuning Research Work (Reuters) HER2 Testing Guide Clarifies Rules & Processes (MedPage...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs